{"result": "(\"entity\"<|>AMINOÁCIDO<|>EVENT<|>Aminoácido inestable e insoluble que debe formularse en forma de dipéptidos de L-alanil-L-glutamina, utilizado en tratamientos médicos)\n##\n(\"entity\"<|>DIPÉPTIDOS DE L-ALANIL-L-GLUTAMINA<|>EVENT<|>Forma recomendada para la administración de un aminoácido inestable e insoluble, utilizada en tratamientos médicos)\n##\n(\"entity\"<|>AMERICAN MEDICAL ASSOCIATION<|>ORGANIZATION<|>Organización que proporciona recomendaciones diarias de vitaminas y oligoelementos para la nutrición parenteral)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL (NP)<|>EVENT<|>Método de alimentación que proporciona nutrientes directamente en el torrente sanguíneo, utilizado en pacientes que no pueden alimentarse por vía oral)\n##\n(\"entity\"<|>VITAMINAS<|>EVENT<|>Nutrientes esenciales que deben administrarse desde el principio de la nutrición parenteral para evitar deficiencias)\n##\n(\"entity\"<|>OLIGOELEMENTOS<|>EVENT<|>Nutrientes necesarios en pequeñas cantidades, cuya administración es recomendada por la American Medical Association)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL (NP)<|>AMINOÁCIDO<|>El aminoácido es utilizado en la nutrición parenteral para el soporte nutricional de pacientes<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL (NP)<|>DIPÉPTIDOS DE L-ALANIL-L-GLUTAMINA<|>Los dipéptidos son la forma recomendada de un aminoácido utilizado en la nutrición parenteral<|>8)\n##\n(\"relationship\"<|>AMERICAN MEDICAL ASSOCIATION<|>VITAMINAS<|>La American Medical Association proporciona recomendaciones sobre la administración de vitaminas en la nutrición parenteral<|>7)\n##\n(\"relationship\"<|>AMERICAN MEDICAL ASSOCIATION<|>OLIGOELEMENTOS<|>La American Medical Association proporciona recomendaciones sobre la administración de oligoelementos en la nutrición parenteral<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL (NP)<|>VITAMINAS<|>Las vitaminas son un componente esencial de la nutrición parenteral para evitar deficiencias<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL (NP)<|>OLIGOELEMENTOS<|>Los oligoelementos son necesarios en la nutrición parenteral para cubrir los requerimientos nutricionales<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , trasplante de precursores hematopoyéticos, grandes quemados, enfermedades inflamatorias intestinales, intestino corto, enteritis post-radiación y quimioterapia), aunque son necesarios más estudios para demostrar su eficacia.\n\nSe trata de un aminoácido inestable e insoluble por lo que debe formularse en forma de dipéptidos de L-alanil-L-glutamina. Las dosis recomendadas son de 20-40 g /día, o de 0,3-0,5g/Kg/día, y no está clara la duración del tratamiento pero no debe ser inferior a 5 días. Existe controversia sobre su suplementación, ya que en algunos estudios se ha observado un incremento de la mortalidad en el paciente crítico con fallo multiorgánico.\n\n### 3.2 AGUA Y ELECTROLITOS\n\nLos requerimientos de fluidos varían con la edad y el peso y deben ajustarse en función de estos parámetros y la situación clínica (35-50 ml/kg).\n\nPor lo que respecta al límite inferior es necesario al menos 1000-1500 ml en la NP para obtener un soporte nutricional mínimo eficaz.\n\nLa NP también contiene los electrolitos en cantidad suficiente para cubrir los requerimientos. Si existe déficit de alguno de ellos pueden aportarse en la NP siempre que se garantice la estabilidad de la mezcla.\n---\n| Recomendaciones diarias de minerales. |                    |\n|---------------------------------------|----------------------------|\n| Fosfato                               | 20-40 mmol/día             |\n| Sodio                                 | 60-150 mEq/día             |\n| Potasio                               | 60-120 mEq/día             |\n| Calcio                                | 10-15 mEq/día              |\n| Magnesio                              | 8-20 mEq/día               |\n| Cloruro y acetatos                    | Según equilibrio ácido-base |\n\nHay que tener en cuenta que es necesario aportar entre 4-6 mEq de potasio por cada gramo de N aportado para su correcta utilización, así como 10-15 mMol de fósforo por cada 1000 Kcal.\n\n### 3.3. MICRONUTRIENTES\n\nVitaminas\n\nPara evitar posibles deficiencias, las vitaminas deben administrarse desde el principio de la NP, añadiéndose a la bolsa junto al resto de componentes. Las recomendaciones diarias de vitaminas según la American Medical Association se reflejan en la tabla siguiente.\n\n| Recomendaciones diarias de vitaminas | | Preparado disponible en el hospital |\n|--------------------------------------|------------|----------------------------------|\n| Vitamina A (U.I)                     | 3.300      | 3.500                            |\n| Vitamina D (U.I)                     | 200        | 220                              |\n| Vitamina E (U.I)                     | 10         | 11                               |\n| Vitamina K (mg)                      | 0.5        | ----                             |\n| Vitamina B1 (mg)                     | 3          | 3,51                             |\n| Vitamina B2 (mg)                     | 3.6        | 4,14                             |\n| Niacina (mg)                         | 40         | ---                              |\n| Vitamina B6 (mg)                     | 4          | 5,5                              |\n| Vitamina B12 (microg)                | 5          | 0,006                            |\n| Pantoténico (mg)                     | 15         | 17,25                            |\n| Vitamina C (mg)                      | 100        | 125                              |\n| Acido fólico (mg)                    | 0,4        | 0,4                              |\n| Biotina (microgr)                    | 60         | 69                               |\n---\nA tener en cuenta:\n\n- Los aportes señalados no son suficientes si existe previamente algún déficit vitamínico, en cuyo caso se suplementará con preparados individuales.\n\n- En situaciones de estrés los requerimientos de vitamina C están aumentados (500-1000 mg/día)\n\n- La vitamina K no forma parte de ningún preparado comercial multivitamínico por lo que se aconseja su administración independiente 1-2 veces a la semana, monitorizando el tiempo de protrombina.\n\n- El ácido fólico, la cianocobalamina y la biotina pueden no estar presentes en los preparados comerciales, en cuyo caso se suplementarán individualmente. Pueden producirse déficits de biotina en las NP prolongadas.\n\nOligoelementos\n\nLos requerimientos (según la American Medical Association) aparecen en la tabla siguiente.\n\n| Recomendaciones diarias de oligoelementos (mg). | Preparado disponible en el hospital |\n|--------------------------------------------------|-------------------------------------|\n| Zinc                                             | 2,5-4                               | 3     |\n| Cobre                                            | 0,5-1,5                             | 0,8   |\n| Cromo                                            | 0,01-0,02                           | 0,2   |\n| Manganeso                                        | 0,15-0,8                            | 0,36  |\n| Cobalto                                          | 0,002-0,005                         | ---   |\n|\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}